Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER) | MicrobiomeTrials← Back to trialsNCT07499362
Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-03-26Est. Completion: 2029-11-22
Enrollment target: 20 participants Locations- National Cancer Center Hospital, Chūōku, Japan
- Kyushu University Hospital - 300173484, Fukuoka, Japan
- Nagoya University Hospital - 300176284, Nagoya, Japan
Other microbiome trials you might be interested in
Neurofibroma, PlexiformPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Promyelocytic, AcuteSarcoma
Background:
\- Some people with cancer have solid tumors. Others have refractory leukemia. This may not go away after t…
Bethesda, United StatesEst. completion Dec 31, 2026
Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma
Angiomatoid Fibrous Histiocytoma
Myoepithelioma
Fibrosarcoma NOS
Myxofibrosarcoma
Angiosarcoma
Osteosarcoma, Extraskeletal
The study participant has been diagnosed with non-rhabdomyosarcoma (NRSTS).
Primary Objectives
Intermediate-Risk
* To…
Atlanta, United StatesEst. completion Jun 2034